Table 2 Details of the brain samples used for the spatial analysis.

From: Human iPSC-derived microglia carrying the LRRK2-G2019S mutation show a Parkinson’s disease related transcriptional profile and function

Patient No

Age

Sex

PMD

PD Braak

AD Braak

PD cases

 PD1

80

F

37,10

5

II

 PD2

78

M

54,55

5

II

 PD3

79

F

46,20

6

I

 PD4

89

M

39,00

6

II

 PD5

83

F

41,00

6

II

 PD6

81

M

38,00

6

II

 PD7

83

M

29,45

6

II

Controls

 CTRL1

86

F

40,20

N/A

N/A

 CTRL2

87

F

51,45

N/A

I

 CTRL3

89

M

38,30

N/A

III

 CTRL4

83

M

63,30

N/A

III

 CTRL5

76

M

79,00

N/A

II

 CTRL6

92

F

86,50

N/A

III

 CTRL7

91

F

71,40

N/A

II

 CTRL8

96

F

36,00

N/A

II

  1. PMD = post mortem delay (hours). PD Braak defined by score for Lewy bodies (a-synuclein staining). Alzheimer’s disease (AD) Braak stage defined by Amyloid-β staining, no pathological diagnosis for neurodegenerative diseases. N/A: not available.
Back to article page